• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用空间转录组学探索混合性神经内分泌-非神经内分泌肿瘤的瘤内异质性:比预期更加多样。

Exploring Intratumoral Heterogeneity in Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than Anticipated.

作者信息

Weiß Annika, Teply-Szymanski Julia, Schmitt Maxime, Foersch Sebastian, Jank Paul, Griger Joscha, Wagner Uwe, Bartsch Detlef K, Denkert Carsten, Jesinghaus Moritz

机构信息

Institute of Pathology, Philipps University Marburg und University Hospital Marburg, Marburg, Germany.

Institute of Pathology, University Hospital Mainz, Mainz, Germany.

出版信息

Endocr Pathol. 2025 Aug 20;36(1):29. doi: 10.1007/s12022-025-09869-w.

DOI:10.1007/s12022-025-09869-w
PMID:40833530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12367963/
Abstract

Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNEN) are usually highly aggressive tumors characterized by marked histological heterogeneity, most commonly represented by mixed adenocarcinoma and poorly differentiated neuroendocrine carcinoma (NEC). However, beyond morphological observations, the biological basis and implications of this heterogeneity remain incompletely understood. In this study, we combined component-specific next-generation sequencing and spatial transcriptomics to investigate three mixed adenocarcinoma-NEC cases from different anatomical sites (ileocecal, ovarian, gastric), tracing tumor progression from precursor lesions to invasive NEC. Genomic analyses revealed a shared trunk of driver mutations across all tumor compartments, confirming their clonal origin, while also uncovering additional compartment-specific alterations. Spatial transcriptomics, together with gene set enrichment analysis (GSEA), revealed distinct transcriptional profiles aligned with histologically annotated compartments (e.g., adenocarcinoma, NEC, precursor). In NECs, GSEA consistently showed downregulation of immune-related pathways and upregulation of proliferation-associated pathways compared to non-neuroendocrine tumor areas. Moreover, distinct transcriptomic subclusters were identified within morphologically homogeneous NEC regions in two of the three cases. These subclusters exhibited significant differences in immune regulation, proliferation signaling, and cell-cycle control, and were associated with divergent predicted chemotherapy-response signatures, suggesting clinically relevant implications for treatment sensitivity and resistance. In summary, our findings indicate that despite a shared clonal origin, MiNEN develop distinct genetic and transcriptomic features across tumor compartments. The inconsistent presence of transcriptomic subclusters within morphologically similar regions underscores the complexity of intratumoral heterogeneity in these aggressive neoplasms. By connecting morphological and molecular layers of tumor architecture, spatial profiling may aid in translating biological complexity into more targeted clinical strategies.

摘要

混合性神经内分泌-非神经内分泌肿瘤(MiNEN)通常是高度侵袭性肿瘤,其特征为显著的组织学异质性,最常见的表现是腺癌与低分化神经内分泌癌(NEC)混合。然而,除了形态学观察外,这种异质性的生物学基础和影响仍未完全明确。在本研究中,我们结合成分特异性的下一代测序和空间转录组学,对来自不同解剖部位(回盲部、卵巢、胃)的三例腺癌-NEC混合病例进行研究,追踪肿瘤从前体病变到侵袭性NEC的进展。基因组分析揭示了所有肿瘤区域存在共同的驱动基因突变主干,证实了它们的克隆起源,同时也发现了其他区域特异性改变。空间转录组学与基因集富集分析(GSEA)显示,不同的转录谱与组织学注释区域(如腺癌、NEC、前体)一致。在NEC中,与非神经内分泌肿瘤区域相比,GSEA始终显示免疫相关通路下调,增殖相关通路上调。此外,在三例中的两例形态学上均一的NEC区域内鉴定出不同的转录组亚群。这些亚群在免疫调节、增殖信号传导和细胞周期控制方面表现出显著差异,并与不同的预测化疗反应特征相关,提示对治疗敏感性和耐药性具有临床相关意义。总之,我们的研究结果表明,尽管MiNEN有共同的克隆起源,但在肿瘤区域间会出现不同的遗传和转录组特征。形态学相似区域内转录组亚群的不一致存在突出了这些侵袭性肿瘤瘤内异质性的复杂性。通过连接肿瘤结构的形态学和分子层面,空间分析可能有助于将生物学复杂性转化为更具针对性的临床策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/95e795098f13/12022_2025_9869_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/9ebdf27db462/12022_2025_9869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/04fe9e51ca3f/12022_2025_9869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/ba6a74b081a4/12022_2025_9869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/843026d25af4/12022_2025_9869_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/fedee172f6a5/12022_2025_9869_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/83c0dec87600/12022_2025_9869_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/6a2285422232/12022_2025_9869_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/cd0d11f00ae3/12022_2025_9869_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/7ed8e48d9715/12022_2025_9869_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/95e795098f13/12022_2025_9869_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/9ebdf27db462/12022_2025_9869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/04fe9e51ca3f/12022_2025_9869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/ba6a74b081a4/12022_2025_9869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/843026d25af4/12022_2025_9869_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/fedee172f6a5/12022_2025_9869_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/83c0dec87600/12022_2025_9869_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/6a2285422232/12022_2025_9869_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/cd0d11f00ae3/12022_2025_9869_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/7ed8e48d9715/12022_2025_9869_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b922/12367963/95e795098f13/12022_2025_9869_Fig10_HTML.jpg

相似文献

1
Exploring Intratumoral Heterogeneity in Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than Anticipated.利用空间转录组学探索混合性神经内分泌-非神经内分泌肿瘤的瘤内异质性:比预期更加多样。
Endocr Pathol. 2025 Aug 20;36(1):29. doi: 10.1007/s12022-025-09869-w.
2
Genomic Signatures of Gastric Adenocarcinoma By Tumor Location-Modified Laurén Classification: Highlighting the Molecular Heterogeneity of Mixed-Type Tumors.基于肿瘤位置改良的劳伦分类法的胃腺癌基因组特征:突显混合型肿瘤的分子异质性
Am J Surg Pathol. 2025 Jun 13;49(9):948-955. doi: 10.1097/PAS.0000000000002432.
3
Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early-stage lung adenocarcinoma.跨组织学亚型的空间转录组分析揭示了早期肺腺癌的分子异质性和预后标志物。
Clin Transl Med. 2025 Aug;15(8):e70439. doi: 10.1002/ctm2.70439.
4
Prognostic and predictive significance of p53 and ATRX in neuroendocrine neoplasms of GIT and pancreas and their utility as an adjunct to accurate diagnosis-An eight-year retrospective study.p53和ATRX在胃肠道及胰腺神经内分泌肿瘤中的预后和预测意义及其作为准确诊断辅助手段的效用——一项八年回顾性研究
Indian J Gastroenterol. 2025 Feb;44(1):95-102. doi: 10.1007/s12664-024-01678-z. Epub 2024 Oct 1.
5
Spatial transcriptomics reveal PI3K-AKT and metabolic alterations in aggressive, treatment-resistant lactotroph pituitary neuroendocrine tumors.空间转录组学揭示侵袭性、耐药性催乳素细胞垂体神经内分泌肿瘤中的PI3K-AKT和代谢改变。
Acta Neuropathol Commun. 2025 May 19;13(1):107. doi: 10.1186/s40478-025-02025-9.
6
Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis.胃神经内分泌肿瘤的临床病理特征:全面分析。
Cancer Med. 2024 Feb;13(4):e7011. doi: 10.1002/cam4.7011.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.胃混合性神经内分泌-非神经内分泌肿瘤中神经内分泌癌和腺癌成分的染色体和分子通路改变。
Mod Pathol. 2020 Dec;33(12):2602-2613. doi: 10.1038/s41379-020-0579-z. Epub 2020 May 27.
9
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?胃肠道管状非小细胞型高级别神经内分泌癌是一种独特的疾病实体吗?
Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.
10
Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms.基于综合基因组分析的胃肠胰神经内分泌肿瘤治疗药物选择评估
PLoS One. 2025 Aug 6;20(8):e0325727. doi: 10.1371/journal.pone.0325727. eCollection 2025.

本文引用的文献

1
Investigation into the Spatial Heterogeneity of Lung Composite Large-Cell Neuroendocrine Carcinoma Spatial Transcriptomic Analysis of Combined Large-Cell Neuroendocrine Carcinoma.肺复合性大细胞神经内分泌癌的空间异质性研究 联合大细胞神经内分泌癌的空间转录组分析
Cancer Biother Radiopharm. 2025 Apr 30. doi: 10.1089/cbr.2025.0043.
2
Spatial landscapes of cancers: insights and opportunities.癌症的空间格局:见解与机遇
Nat Rev Clin Oncol. 2024 Sep;21(9):660-674. doi: 10.1038/s41571-024-00926-7. Epub 2024 Jul 23.
3
Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma.
胃混合性腺神经内分泌癌中神经内分泌癌和腺癌成分的独特表型和微环境特征。
Mod Pathol. 2024 Oct;37(10):100568. doi: 10.1016/j.modpat.2024.100568. Epub 2024 Jul 17.
4
Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration.食管腺癌中的胎儿肠道细胞样分化定义了一种具有治疗相关 Claudin-6 阳性和 SWI/SNF 基因突变的罕见肿瘤亚型。
Sci Rep. 2024 Jun 12;14(1):13474. doi: 10.1038/s41598-024-64116-2.
5
Mechanisms of metastatic colorectal cancer.转移性结直肠癌的发病机制。
Nat Rev Gastroenterol Hepatol. 2024 Sep;21(9):609-625. doi: 10.1038/s41575-024-00934-z. Epub 2024 May 28.
6
Metabolic heterogeneity in cancer.癌症中的代谢异质性。
Nat Metab. 2024 Jan;6(1):18-38. doi: 10.1038/s42255-023-00963-z. Epub 2024 Jan 24.
7
Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma.晚期低分化肺外神经内分泌癌的化疗选择
Cancers (Basel). 2023 Oct 11;15(20):4951. doi: 10.3390/cancers15204951.
8
High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.胰岛素瘤相关蛋白1(INSM1)的高表达可将结直肠混合性和纯神经内分泌癌与突触素弥漫性表达的传统腺癌区分开来。
J Pathol Clin Res. 2023 Nov;9(6):498-509. doi: 10.1002/cjp2.339. Epub 2023 Aug 22.
9
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer.肿瘤异质性对癌症演进和治疗抵抗的影响:来自乳腺癌的教训。
J Pathol. 2023 Aug;260(5):621-636. doi: 10.1002/path.6158. Epub 2023 Aug 16.
10
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets.胃神经内分泌癌演进的综合细胞和分子模型突出了治疗靶点。
Cancer Cell. 2023 Jul 10;41(7):1327-1344.e10. doi: 10.1016/j.ccell.2023.06.001. Epub 2023 Jun 22.